Log in

canadian entrepreneurs in life science



    • February 09, 2022
    • 9:00 AM - 11:00 AM
    • Virtual

    Join us February 9th, 2022 for our Valley Ready Demo Day.

    This event will showcase some amazing innovations from 8 Canadian life science companies.

    Our CELS Valley Ready program is designed to prepare Canadian life science companies for U.S. market entry or capital. The 4-month program includes workshops, 1:1 mentorship, network connections, and a Demo Day showcase.

    Join us on February 9th to learn more about these amazing startups along with insights from Silicon Valley leaders.

    Companies Presenting:

    1. Bio-Stream Diagnostics Inc. - Bio-Stream Diagnostics Inc has developed a new kind of disposable COVID-19 test that is perfectly suited for keeping people safe at work, school or for travel. It is comprised of a thin-film biosensor embedded in a testing strip (think glucose monitoring). A sample of saliva is dropped on the strip. The strip is inserted into a handheld device which registers a voltage change in the presence of the SARS-CoV-2 virus. Highly accurate results are returned in 3 minutes via a mobile App. The test is made using well established manufacturing processes that can produce millions of strips daily at very low cost. The Bio-Stream GO test will revolutionize the global testing market for COVID and other pathogens.
    2. Fe Pharmaceuticals - Fe Pharmaceuticals is reversing the effects of disrupted iron management in disease. Dysregulation of iron homeostasis can lead to or exacerbate a wide variety of diseases including infection, cancer, and inflammatory diseases. Fe Pharmaceuticals is developing DIBI, a non-toxic, iron-binding copolymer, as a potent, broad-spectrum, antimicrobial agent active against bacterial and fungal infections, including drug resistant organisms. DIBI starves infections for essential iron. DIBI is also effective against sepsis, inflammatory disorders, and cancer. This water-soluble polymer is ideal for many routes of administration and has been characterized in 22 published studies. It is non-toxic in animal studies and is immune to the development of microbial resistance and inhibits the development of resistance to co-administered antibiotics with which it is synergistic. NIAID is supporting development and MBC Biolabs has accepted our US subsidiary into its Bay area incubator. The company is raising a Series A to advance DIBI through Phase 1.
    3. Mesintel Therapeutics - Mesintel has developed a proprietary target discovery platform that incorporates our extensive knowledge of mesenchymal progenitor (MP) biology, coupled with disease-specific datasets mined by state-of-the-art AI/ML capabilities. The platform is designed to accelerate the development of therapeutics centered around the key role MPs play in driving disease, including rare oncology and the solid tumor microenvironment. These efforts will enable Mesintel to leverage its platform into complementary therapeutic areas, such as rare disease, fibrosis, tissue regeneration and aging. We are seeking opportunities to propel collaborative discovery and development partnerships, and seed funding to advance internal programs and platform capabilities.
    4. Nanology Labs - Nanology Labs is a biotechnology company focused on advancing the development of T-MX, a first-in-class nanomedicine that modifies the tumor microenvironment and improves therapeutic outcomes in the treatment of solid tumor cancers, leading to better survival and quality of life. The company also pursues collaborations with strategic partners to develop new precision medicines enabled by its proprietary drug delivery platform technology (TERP), which has a high degree of payload and targeting flexibility, with intrinsic capability for active transport into cells and across the blood-brain-barrier.
    5. Outbreaker Solutions - Outbreaker Solutions is developing and commercializing a patented, fast-acting antimicrobial touch surface made from compressed sodium chloride (CSC). CSC is integrated with commonly touched surfaces to become the contact point and continuously reduce the spread of harmful pathogens. CSC achieves a 99.9% reduction of bacteria, fungi and viruses in less than 2 minutes.
    6. Synapsis Medical - We are a medical wearable and smart apparel company focused on optimizing health and longitivtiy using clinically proven parameters and interventions. Our vision is to provide immediate feedback on user behaviour and to automate healthy habits.
    7. Zilia - Zilia is a health tech company developing a non-invasive platform to measure biomarkers in the eye and our initial focus is ocular oximetry or oxygen saturation. This key element has been abundantly linked throughout the literature with three main causes of preventable blindness such as glaucoma, diabetic retinopathy, and age-related macular degeneration, and by quantifying this biomarker for the first time, we aim to prevent and better manage these diseases. Finally, for us, eye care is just the beginning as our platform can be adapted to assess other biomarkers in neurological and systemic disorders for instance.
    8. Scanbo - Medical Diagnostic tests are expensive, time consuming and inconvenient globally. Disease. Diagnostic tests play a crucial role at every step of disease management – Diagnosis, Monitoring, Screening and Prognosis.
      Scanbo platform reduces time for the medical diagnostics, makes it available at point of care and reduces the cost by 30-50%. Overall it leads to better outcome, early treatment and improves mental health.

    The Mission

    CELS is a not for profit association supporting the advancement of innovative Canadian Life Science businesses in the San Francisco Bay Area and Silicon Valley through the power of Community and Connections.

    Why CELS?

    Canadian Life Science Start-Ups are challenged to successfully achieve their funding objectives in one of the most progressive investment communities in the world... Silicon Valley. To succeed in the Bay Area, Canadian Entrepreneurs must adapt to succeed.

Past events

July 09, 2021 Demo Day - Valley Ready Program
March 26, 2021 CELS Valley Ready Program - Applications Due
February 05, 2021 Seizing the Opportunity: A Vaccine Story
December 04, 2020 CELS Valley Ready (VR) Demo Day
November 13, 2020 SVB - HealthTech: Thrust into the Limelight by a Pandemic
October 30, 2020 Applied AI Innovations for Hospitals
October 23, 2020 Pitching to Silicon Valley Investors - How Early Startups Position Themselves for Success
September 11, 2020 Cleveland Clinic: Innovation in the Post-Covid World
September 10, 2020 JLabs Event: A Glimpse into the Mind of the Investor
September 02, 2020 JLabs Event: Got a Plan?... Your Guide to Filing a Large or Small Molecule IND
August 28, 2020 Case Study: Product Design – Canadian Start-Up Preparing for the FDA
August 26, 2020 JLabs Event: Grow Your Biotech - Marketing Fundamentals, Online Presence & Content
August 14, 2020 Deloitte: Life Science & MedTech Investing in The Future of Health
July 24, 2020 Advamed: Small MedTech Companies in the Time of Coronavirus
July 10, 2020 CELS Town Hall Meeting - Major Program Announcement
July 10, 2020 An Angel's View: The State of Early Stage Funding in 2020
June 19, 2020 IP and Startup Valuations in Times of Crisis
June 05, 2020 The Future of Telehealth
May 22, 2020 Survival Tips for Life Science Start-Ups during Covid-19
May 13, 2020 A Conversation with Canadian health innovators playing a role in the fight against COVID-19
May 06, 2020 Healthcare Investments in the Age of COVID-19
May 01, 2020 CELS Valley Ready: Market Access (USA)- Covid-19 Opportunities & Challenges
March 03, 2020 Digital Moose Lounge: Maple Leafs vs. Sharks
January 29, 2020 DML: Canucks vs. Sharks
January 13, 2020 CELS Valley-Ready Program Briefing
January 13, 2020 Canada Meeting Center @ JPM 2020 Healthcare Conference Week
January 13, 2020 BIOTECanada Networking Breakfast
November 19, 2019 CELS Forum: Practical Guide for Investing in Canadian Life Science Companies
May 16, 2019 Wearables in Health: It is all in the data
May 15, 2019 Digital Moose Lounge - Chesterfield Chat
February 12, 2019 CELS Meet-Up - Dose of the Valley
January 07, 2019 Canada Meeting Center @ JPM 2019 Healthcare Conference Week
November 16, 2018 JPM 101: Preparing for the JP Morgan Healthcare Conference
November 13, 2018 CELS Forum: How to get Funded in Health Tech
November 06, 2018 CELS Meet-Up: November Edition
October 30, 2018 The Great Debate: Understanding when equity & debt will maximize your company’s potential
October 23, 2018 How to Make The Right Connections in Silicon Valley
September 04, 2018 FEMTECH HAPPY HOUR
June 29, 2018 Canada Day Celebration (San Jose)
June 05, 2018 CELS Meet-Up: June Edition
May 01, 2018 CELS Meet-Up: May Edition
April 03, 2018 CELS Meet-Up: April Edition
March 06, 2018 CELS Meet-Up: NEW EVENT!
February 13, 2018 CELS Forum: Academic Research to Patient Solutions
January 08, 2018 CELS Meeting Center - JP Morgan 2018
December 06, 2017 CELS Forum: Integrated Care
October 10, 2017 CELS COHORT Mentor Program - Launch Event

© 2021 Canadian Entrepreneurs in Life Science. All Rights Reserved.